DMP-565

Known as: DMP 565 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2012
02419832012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Schweinfurthins are potent inhibitors of cancer cell growth, especially against human central nervous system tumor lines such as… (More)
Is this relevant?
2012
2012
The neutral tris(semiquinonate) complex [Ti(dmp-BIAN(isq))(3)] [dmp-BIAN(isq) = N,N'-bis(3,5-dimethylphenylimino… (More)
Is this relevant?
1998
1998
The cure rate of acute myeloid leukemia might increase if G-CSF were given concurrently with repeated postremission chemotherapy… (More)
Is this relevant?
1997
1997
A 18-year old female with acute myelogenous leukemia (AML), M2 had translocation: t(6;9) (p23; q34). The patient entered into… (More)
Is this relevant?
1996
1996
Patient 1 was a 36-year-old male and diagnosed as APL in April 1989, and treated with BHAC-DMP and BHAC-AMP. In January 1990, a… (More)
Is this relevant?
1995
1995
We demonstrate two conventional chemotherapy-resistant cases of acute promyelocytic leukemia (APL) who were successfully treated… (More)
Is this relevant?
1994
1994
A 54-year-old man was admitted with pneumonia and pancytopenia (WBC 400/microliters, RBC 297 x 10(4)/microliters, Hb 10.1g/dl… (More)
Is this relevant?
1992
1992
We asked 2 questions in this study. First was the additional effect of VCR in induction therapy, and the second was the duration… (More)
Is this relevant?
1989
1989
A 53-year-old female, who had been having xerostomia and xerophthalmia for two years, was admitted in November 1984, because of… (More)
Is this relevant?
1986
1986
Fifty-one consecutive previously untreated adult patients with acute myelogenous leukemia (AML) were treated with BHAC-DMP (N4… (More)
Is this relevant?